Save your place

Sign in to WhoBought

Please try again later.

CVS Health Corp. (CVS) institutional ownership

Latest close $107.61 Jul 20, 2026
Market cap$132.2B 52-week range SectorHealthcare
Funds holding · Q1 2026
1,802
reported CVS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net sold $2.3B
864 buyers · 938 sellers

CVS Health Corp. (CVS) price and institutional activity

Dates

Q1 2026

$5.6B bought by 864 investors
Capital World Investors$739MCapital Research Global Investors$614M +862 more
$7.9B sold by 938 investors
Norges-$1.6BCapital International Investors-$940M +936 more
Bought Sold Totals per quarter; hover a bar for the names.

CVS Health Corp. (CVS) institutional activity · 1,802

Investor Type Est. change Change Δ Own Date
Norges · Exited −$1.6B
Change −21.0M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −$1.6B −21.0M −100.0% Q1 2026
Capital International Investors · Reduced −$940M
Change −12.2M Date Q1 2026
Capital International Investors Reduced· Q1 2026 −$940M −12.2M Q1 2026
Dodge & Cox · Reduced −$827M
Change −10.7M Δ Own −17.2% Date Q1 2026
Dodge & Cox Reduced· Q1 2026 −$827M −10.7M −17.2% Q1 2026
FMR LLC · Reduced −$757M
Change −9.8M Δ Own −23.9% Date Q1 2026
FMR LLC Reduced· Q1 2026 −$757M −9.8M −23.9% Q1 2026
Capital World Investors · Added +$739M
Change +9.6M Date Q1 2026
Capital World Investors Added· Q1 2026 +$739M +9.6M Q1 2026
Capital Research Global Investors · Added +$614M
Change +8.0M Δ Own +66.2% Date Q1 2026
Capital Research Global Investors Added· Q1 2026 +$614M +8.0M +66.2% Q1 2026
T. Rowe Price Associates · Added +$565M
Change +7.3M Date Q1 2026
T. Rowe Price Associates Added· Q1 2026 +$565M +7.3M Q1 2026
BlackRock · Added +$380M
Change +4.9M Date Q1 2026
BlackRock Added· Q1 2026 +$380M +4.9M Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main · Reduced −$351M
Change −4.6M Date Q1 2026
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt AM Main Reduced· Q1 2026 −$351M −4.6M Q1 2026
Goldman Sachs Group Inc · Added +$340M
Change +4.4M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +$340M +4.4M Q1 2026
Wellington Management Group LLP · Added +$308M
Change +4.0M Δ Own +21.6% Date Q1 2026
Wellington Management Group LLP Added· Q1 2026 +$308M +4.0M +21.6% Q1 2026
Millennium Management LLC · Reduced −$252M
Change −3.3M Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −$252M −3.3M Q1 2026
Sachem Head Capital Management LP · Exited −$199M
Change −2.6M Δ Own −100.0% Date Q1 2026
Sachem Head Capital Management LP Exited· Q1 2026 −$199M −2.6M −100.0% Q1 2026
Morgan Stanley · Reduced −$196M
Change −2.5M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −$196M −2.5M Q1 2026
Point72 Asset Management, L.P. · Exited −$161M
Change −2.1M Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −$161M −2.1M −100.0% Q1 2026
Data through Q1 2026 · filed Jun 11, 2026
15 of 1802

Famous investor activity in CVS Health Corp. (CVS)

CVS Health Corp. (CVS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Clark James David · Officer Tax withholding or exercise payment (F) -$41K
Price $90.98 Qty -454 Owned 28K ΔOwn −1.6% Trade date Jun 26, 2026 Filed date Jun 29, 2026
Clark James David Officer Tax withholding or exercise payment (F) $90.98 -454 -$41K 28K −1.6% Jun 26, 2026 Jun 29, 2026
Newman Brian · CFO Tax withholding or exercise payment (F) -$225K
Price $90.98 Qty -2K Owned 3K Trade date May 31, 2026 Filed date Jun 1, 2026
Newman Brian CFO Tax withholding or exercise payment (F) $90.98 -2K -$225K 3K May 31, 2026 Jun 1, 2026
Compton-Phillips Amy · Officer Tax withholding or exercise payment (F) -$693K
Price $90.98 Qty -8K Owned 10K Trade date May 31, 2026 Filed date Jun 1, 2026
Compton-Phillips Amy Officer Tax withholding or exercise payment (F) $90.98 -8K -$693K 10K May 31, 2026 Jun 1, 2026
Aguirre Fernando · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -$146K
Price $93.50 Qty -2K Owned 11K Trade date May 21, 2026 Filed date May 22, 2026
Aguirre Fernando Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale $93.50 -2K -$146K 11K May 21, 2026 May 22, 2026
Robbins Larry · Director Sell −$35M
Price $93.45 Qty −370K Owned 4.8M Trade date May 21, 2026 Filed date May 21, 2026
Robbins Larry Director Sell $93.45 −370K −$35M 4.8M May 21, 2026 May 21, 2026
Robbins Larry · Director Other Form 4 event (S, derivative) -$35M
Price $93.31 Qty -378K Owned 0 Trade date May 21, 2026 Filed date May 21, 2026
Robbins Larry Director Other Form 4 event (S, derivative) $93.31 -378K -$35M 0 May 21, 2026 May 21, 2026
Aguirre Fernando · Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale -$2.9M
Price $93.78 Qty -30K Owned 12K Trade date May 20, 2026 Filed date May 22, 2026
Aguirre Fernando Director Shares transferred outside the market (D), often for tax or as a gift, not a market sale $93.78 -30K -$2.9M 12K May 20, 2026 May 22, 2026
Robbins Larry · Director 4 operations −$96M
Price $93.48–$96.28 Qty −1.0M Owned 5.2M Trade date May 20, 2026 Filed date May 21, 2026
Robbins Larry Director 4 operations $93.48–$96.28 −1.0M −$96M 5.2M May 20, 2026 May 21, 2026
Robbins Larry · Director 2 operations −$187M
Price $94.45–$95.18 Qty −2.0M Owned 6.2M Trade date May 19, 2026 Filed date May 21, 2026
Robbins Larry Director 2 operations $94.45–$95.18 −2.0M −$187M 6.2M May 19, 2026 May 21, 2026
Gallina John E. · Director Grant (A) $141K
Price $97.15 Qty 1K Owned 1K Trade date May 14, 2026 Filed date May 15, 2026
Gallina John E. Director Grant (A) $97.15 1K $141K 1K May 14, 2026 May 15, 2026
Mahoney Michael F. · Director Grant (A) $169K
Price $97.15 Qty 2K Owned 6K Trade date May 14, 2026 Filed date May 15, 2026
Mahoney Michael F. Director Grant (A) $97.15 2K $169K 6K May 14, 2026 May 15, 2026
Aguirre Fernando · Director Grant (A) $152K
Price $97.15 Qty 2K Owned 43K Trade date May 14, 2026 Filed date May 15, 2026
Aguirre Fernando Director Grant (A) $97.15 2K $152K 43K May 14, 2026 May 15, 2026
Balser Jeffrey R. · Director Grant (A) $200K
Price $97.15 Qty 2K Owned 16K Trade date May 14, 2026 Filed date May 15, 2026
Balser Jeffrey R. Director Grant (A) $97.15 2K $200K 16K May 14, 2026 May 15, 2026
Kirby J. Scott · Director Grant (A) $141K
Price $97.15 Qty 1K Owned 14K Trade date May 14, 2026 Filed date May 15, 2026
Kirby J. Scott Director Grant (A) $97.15 1K $141K 14K May 14, 2026 May 15, 2026
Norwalk Leslie V · Director Grant (A) $141K
Price $97.15 Qty 1K Owned 7K Trade date May 14, 2026 Filed date May 15, 2026
Norwalk Leslie V Director Grant (A) $97.15 1K $141K 7K May 14, 2026 May 15, 2026
15 of 60
15 of 60 Sign in to continue to older insider transactions.

CVS Health Corp. (CVS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Vanguard Group Inc 117.7M
% of shares outstanding 9.1% Filing date Feb 13, 2024
Vanguard Group Inc 117.7M 9.1% Feb 13, 2024
Blackrock, Inc. 104.6M
% of shares outstanding 8.3% Filing date Oct 24, 2024
Blackrock, Inc. 104.6M 8.3% Oct 24, 2024
Vanguard Capital Management LLC 95.6M
% of shares outstanding 7.5% Filing date Apr 29, 2026
Vanguard Capital Management LLC 95.6M 7.5% Apr 29, 2026
BlackRock Inc. 87.0M
% of shares outstanding 6.8% Filing date Jan 26, 2024
BlackRock Inc. 87.0M 6.8% Jan 26, 2024
Dodge & Cox 63.0M
% of shares outstanding 5.0% Filing date Nov 13, 2024
Dodge & Cox 63.0M 5.0% Nov 13, 2024
5 of 5

CVS Health Corp. (CVS) ownership FAQ

Who owns CVS?

1,802 reporting institutions disclosed CVS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.